Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Evofem Biosciences Inc (EVFM)

Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023 ACCESSWIRE - Wed Oct 18, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0096 (+1.05%)
GRI : 1.6000 (-2.44%)
MBRX : 3.63 (+1.68%)
XBIO : 3.74 (-8.69%)
AREC : 0.6551 (-8.12%)
CNSP : 1.4600 (+15.87%)
NVNO : 5.05 (-0.39%)
PALI : 4.35 (-4.19%)
Evofem to Participate in the Virtual Investor Ask the CEO Conference PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Senior...

EVFM : 0.0096 (+1.05%)
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that Padagis Israel Pharmaceuticals Ltd. (Padagis) has withdrawn the Paragraph IV...

EVFM : 0.0096 (+1.05%)
Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the "Company") today announced it has successfully negotiated and entered into a fourth...

EVFM : 0.0096 (+1.05%)
Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange PR Newswire - Tue Aug 22, 2023

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced it has signed a confidential non-binding letter of intent (LOI)...

EVFM : 0.0096 (+1.05%)
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023 PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023....

EVFM : 0.0096 (+1.05%)
Evofem to Participate in the Virtual Investor Summer Spotlight Series PR Newswire - Thu Jul 6, 2023

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced that Saundra Pelletier, Chief Executive Officer, and Amy Raskopf,...

EVFM : 0.0096 (+1.05%)
Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire - Wed May 17, 2023

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced a 1-for-125 reverse stock split of the Company's common stock, which...

EVFM : 0.0096 (+1.05%)
Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update PR Newswire - Fri Apr 28, 2023

/PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), has reported financial...

EVFM : 0.0096 (+1.05%)
Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary PR Newswire - Fri Apr 14, 2023

/PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced the...

EVFM : 0.0096 (+1.05%)

Barchart Exclusives

Where are Animal Proteins Prices Heading in Q3 and Beyond? Barchart - Thu Jul 4, 12:57PM CDT
The animal protein sector of the commodities market, including live and feeder cattle and lean hog futures, edged marginally higher in Q2. Meats are now in the middle of the peak demand season, when prices tend to reach annual highs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot